Furthermore, we have shown that H. pylori-infected gerbils treated with the SMOX inhibitor MDL 72527 exhibited significantly reduced dysplasia and carcinoma [13], which was also seen in our genetic ablation of Smox in the FVB/N INS-GAS model. Here, SMOX is linked to dysplasia.